SCAVONE, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 2.438
EU - Europa 2.324
AS - Asia 2.069
SA - Sud America 202
AF - Africa 60
OC - Oceania 13
Totale 7.106
Nazione #
US - Stati Uniti d'America 2.344
IT - Italia 775
SG - Singapore 679
CN - Cina 586
GB - Regno Unito 542
HK - Hong Kong 285
DE - Germania 218
SE - Svezia 169
BR - Brasile 166
VN - Vietnam 138
RU - Federazione Russa 137
NL - Olanda 92
IN - India 81
FR - Francia 78
BD - Bangladesh 69
CA - Canada 67
IE - Irlanda 64
FI - Finlandia 63
DK - Danimarca 48
ID - Indonesia 40
JP - Giappone 37
KR - Corea 37
PL - Polonia 26
IR - Iran 21
AR - Argentina 20
AT - Austria 19
ZA - Sudafrica 18
UA - Ucraina 16
BE - Belgio 14
MX - Messico 14
AU - Australia 13
CI - Costa d'Avorio 12
IQ - Iraq 12
PH - Filippine 12
ES - Italia 10
TR - Turchia 10
CH - Svizzera 9
CZ - Repubblica Ceca 8
MA - Marocco 8
PK - Pakistan 8
UZ - Uzbekistan 8
TN - Tunisia 7
SA - Arabia Saudita 6
AL - Albania 5
JO - Giordania 5
EC - Ecuador 4
EG - Egitto 4
MY - Malesia 4
RO - Romania 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CR - Costa Rica 3
HR - Croazia 3
LT - Lituania 3
LU - Lussemburgo 3
MU - Mauritius 3
NP - Nepal 3
TW - Taiwan 3
VE - Venezuela 3
BG - Bulgaria 2
BY - Bielorussia 2
BZ - Belize 2
CL - Cile 2
CM - Camerun 2
CY - Cipro 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ME - Montenegro 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.104
Città #
Southend 482
Singapore 422
Milan 408
Dallas 338
Ashburn 291
Hong Kong 244
Chandler 220
San Jose 134
Beijing 95
Los Angeles 91
Fairfield 82
Frankfurt am Main 79
Council Bluffs 75
Hefei 72
Dublin 64
The Dalles 64
New York 59
Wilmington 59
Ann Arbor 58
Santa Clara 52
Princeton 44
Dearborn 41
Hanoi 41
Munich 41
Houston 37
Helsinki 34
Ho Chi Minh City 34
Toronto 33
Bengaluru 29
Buffalo 28
Lauterbourg 28
Seattle 28
Moscow 27
Guangzhou 26
Jakarta 26
Cambridge 25
Shanghai 23
Seoul 21
Rome 20
São Paulo 19
Tokyo 19
Chicago 17
Nanjing 17
Turku 17
Amsterdam 16
Vienna 16
Woodbridge 16
Brussels 14
Des Moines 14
Redwood City 14
Columbus 13
Johannesburg 13
Tehran 13
Tianjin 13
Abidjan 12
Boardman 12
London 12
Phoenix 12
Shenzhen 12
Brescia 11
Nuremberg 11
Berlin 10
Cangzhou 10
Montreal 10
Rio de Janeiro 10
Boston 9
Genoa 9
Jinan 9
Memphis 9
Palermo 9
San Diego 9
Sunnyvale 9
Turin 9
Warsaw 9
Chennai 8
Düsseldorf 8
Fuzhou 8
Kent 8
San Francisco 8
Atlanta 7
Da Nang 7
Grafing 7
Hangzhou 7
Nanchang 7
Stockholm 7
Agliano Terme 6
Bühl 6
Catania 6
Copenhagen 6
Fremont 6
Hebei 6
Jacksonville 6
Lambeth 6
Lappeenranta 6
Naples 6
Orem 6
Quanzhou 6
Redmond 6
Robat Karim-e Kohneh 6
Baghdad 5
Totale 4.580
Nome #
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 670
In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method 346
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome 323
DOES THE INHIBITION OF P2Y12 INHIBIT THE PRODUCTION OF THROMBOXANE A2 BY PLATELETS? 312
Aspirin responsiveness in essential thrombocythemia 293
Measurement of platelet count with different anticoagulants in thrombocytopenic patients and healthy subjects : accuracy and stability over time 256
Impairment of platelet function in both mild and severe COVID-19 patients 254
MgSO4 anticoagulant prevents pseudothrombocytopenia by preserving the integrity of the platelet GPIIb-IIIa complex 253
Effect of prasugrel in patients with asthma : results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study 252
Platelet adhesion and thrombus formation in microchannels : the effect of assay-dependent variables 242
Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdO×1 nCov-19 vaccine 241
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination 221
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2 217
Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin 213
Aggregometry in the settings of thrombocytopenia, thrombocytosis and antiplatelet therapy 211
The MICELI (MICrofluidic, ELectrical, impedance) : Prototyping a point-of-care impedance platelet aggregometer 206
Effect of platelet count on platelet aggregation measured by impedance aggregometry (Multiplate(™) analyser) and by light transmission aggregometry 204
Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies 184
Acetylsalicylic acid in essential thrombocythemia 174
Prevalence of anti‐platelet factor 4 antibodies in healthy vaccinees with adenoviral vector vaccines—A systematic review and meta‐analysis 171
In vitro variations of Mean platelet volume over time in blood samples collected in different anticoagulants from thrombocytopenic patients and healthy subjects 168
Whole blood platelet aggregation measurement by Multiplate™: potential diagnostic inaccuracy of correcting the results for the sample platelet count 165
Use of Myriocin as co-adjuvant in glaucoma surgery: An in vitro study 160
Time‐dependent in vitro variations of platelet count in samples from subjects with EDTA‐induced pseudothrombocytopenia: A comparative analysis across different anticoagulants 156
Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism 149
Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection 148
Thrombosis and Bleeding in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Systematic Review of Published Cases 145
P2Y12 receptor gene mutations associated with bleeding 144
Usefulness of the INNOVANCE® PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y12 receptor for adenosine diphosphate 138
Reduced platelet count, but no major platelet function abnormalities, are associated with loss of function ATP-binding cassette-1 (ABCA1) gene mutations 137
A case of acquired transient bleeding diathesis associated with acquired platelet storage pool deficiency and defective thromboxane A2 production 131
Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia 127
Variables influencing the in vitro measurement of spontaneous aggregation of human platelets 125
High glucose enhances inflammation-driven platelet adhesion to endothelial cells in vitro 94
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis 54
Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study 54
Totale 7.338
Categoria #
all - tutte 19.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 0 45 49
2021/2022567 33 52 35 39 38 17 43 22 74 47 24 143
2022/2023583 73 92 57 58 44 92 27 46 48 10 27 9
2023/2024477 11 25 18 44 84 38 10 38 8 12 101 88
2024/20251.312 59 140 50 116 87 61 66 103 59 162 151 258
2025/20263.193 330 290 496 292 265 158 458 113 299 203 289 0
Totale 7.338